Live Breaking News & Updates on Society Of Gynecologic Oncology Annual Meeting

Stay updated with breaking news from Society of gynecologic oncology annual meeting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

2023 Yields Several Promising Trial Updates in dMMR/pMMR Endometrial Cancer

Eirwen M. Miller, MD, highlights data that have impacted the treatment armamentarium for patients with endometrial cancer and mismatch repair–deficient or mismatch repair–proficient disease throughout the course of 2023. ....

United States , West Penn , Shannonn Westin , Eirwenm Miller , Christopherb Morse , Allegheny Health Network , University Of Texas Md Anderson Cancer Center , European Society For Medical Oncology , Society Of Gynecologic Oncology Annual Meeting , European Society , Medical Oncology , Science Summit , Allegheny Health Network West Penn Hospital , Allegheny Health , Gynecologic Oncology Annual Meeting , Cancer Center , Endometrial Cancer , Duoe Trial , Nrg Gy018 Trial , Ruby Trial , Attend Trial ,

Dr Pothuri on the Promise of the RUBY and NRG-GY018 Trials in Endometrial Cancer

Bhavana Pothuri, MD, discusses the promise of the phase 3 NRG-GY018 and RUBY trials in patients with endometrial cancer.
....

Bhavana Pothuri , York University , Langone Health , Department Of Obstetrics , School Of Medicine , Society Of Gynecologic Oncology Annual Meeting , New York University , Gynecologic Oncology Annual Meeting , Nyu Langone X27s Perlmutter Cancer Center , Onclive Tv , Gynecologic Oncology , Nrg Gy018 , Endometrial Cancer ,

Dr Pothuri on the Phase 3 NRG-GY018 and RUBY Trials in Endometrial Cancer

Bhavana Pothuri, MD, discusses the phase 3 NRG-GY018 and RUBY trials in patients with endometrial cancer.
....

Bhavana Pothuri , Department Of Obstetrics , School Of Medicine , Society Of Gynecologic Oncology Annual Meeting , York University , Langone Health , New York University , Gynecologic Oncology Annual Meeting , Nyu Langone X27s Perlmutter Cancer Center , Onclive Tv , Gynecologic Oncology , Phase 3 Nrg Gy018 , Ruby Trial ,

GSK : European Medicines Agency validates marketing authorisation application for Jemperli (dostarlimab) plus chemotherapy for the treatment of dMMR/MSI-H primary advanced or recurrent endometrial cancer - Form 6-K

European Medicines Agency validates marketing authorisation application for Jemperli plus chemotherapy for the treatment of dMMR/MSI-H primary advanced or recurrent endometrial cancer

. | April 25, 2023 ....

United Kingdom General , United Kingdom , United States , City Of , Treasure Island , Hesham Abdullah , Steph Mountifield , Dan Smith , Kathleen Quinn , Tim Foley , Jeff Mclaughlin , Camilla Campbell , James Dodwell , Mick Readey , Nick Stone , Josh Williams , Lyndsay Meyer , Committee For Medicinal Products Human , Tesaro Inc , European Commission , Anaptysbio Inc , International Research On Cancer , European Society For Medical Oncology Virtual Plenary , Society Of Gynecologic Oncology Annual Meeting , Kantar Health , Global Head Of Oncology Development ,